Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Andexanet Alfa Pulled From US Market

News Daily News

Andexanet Alfa Pulled From US Market

December 22, 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

April 28, 2025

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

News Conference News ISC 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

February 15, 2024

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

June 05, 2023

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

September 26, 2022

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

July 04, 2022

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

December 13, 2021

Latest Smartphones Likely Pose Little Risk to Patients With ICDs

News Daily News

Latest Smartphones Likely Pose Little Risk to Patients With ICDs

July 28, 2021

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

When a Pacemaker Lead Complicates Transcatheter Tricuspid Replacement: New Insights

News Daily News

When a Pacemaker Lead Complicates Transcatheter Tricuspid Replacement: New Insights

Yael L. Maxwell

August 17, 2020

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

News Conference News ISC 2019

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

February 13, 2019

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

News Conference News AHA 2016

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

November 15, 2016

News Conference News AHA 2016

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

November 14, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.